ACROBiosystems Group

ACROBiosystems Group (founded 2010, listed 2021) is a biotechnology company aiming to be a cornerstone of the global biopharmaceutical and health industries through product and business model innovation. With a presence in North America, Europe, and Asia, it operates offices, R&D centers, and production bases across 10+ locations. The group has long-term partnerships with top pharmaceutical firms and academic institutes and includes subsidiaries like ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.
ACROBiosystems' core offerings include recombinant proteins, kits, antibodies, and scientific services, all supported by strict quality control for applications in drug discovery, CMC, preclinical research, clinical trials, and commercial production. ACROBiosystems is dedicated to accelerating the drug development process and its clinical applications, and contributes to global health.